|
1
|
Mlynarsky L, Menachem Y and Shibolet O:
Treatment of hepatocellular carcinoma: Steps forward but still a
long way to go. World J Hepatol. 7:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei KR, Yu X, Zheng RS, Peng XB, Zhang SW,
Ji MF, Liang ZH, Ou ZX and Chen WQ: Incidence and mortality of
liver cancer in China, 2010. Chin J Cancer. 33:388–394.
2014.PubMed/NCBI
|
|
4
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haraguchi N, Ishii H, Mimori K, Tanaka F,
Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, et al:
CD13 is a therapeutic target in human liver cancer stem cells. J
Clin Invest. 120:3326–3339. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruce WR and Van Der Gaag H: A
quantitative assay for the number of murine lymphoma cells capable
of proliferation in vivo. Nature. 199:79–80. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
11
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheung ST, Cheung PF, Cheng CK, Wong NC
and Fan ST: Granulin-epithelin precursor and ATP-dependent binding
cassette (ABC)B5 regulate liver cancer cell chemoresistance.
Gastroenterology. 140:344–355. 2011. View Article : Google Scholar
|
|
13
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nguyen LV, Vanner R, Dirks P and Eaves CJ:
Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–143.
2012.PubMed/NCBI
|
|
15
|
Pang RW and Poon RT: Cancer stem cell as a
potential therapeutic target in hepatocellular carcinoma. Curr
Cancer Drug Targets. 12:1081–1094. 2012.PubMed/NCBI
|
|
16
|
Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH,
Yao XH, Gao L, Wang JM and Bian XW: Isolation and characterization
of cancer stem cells from a human glioblastoma cell line U87.
Cancer Lett. 265:124–134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang
R, Li J, Zhang Y, Chen L, Qian H, et al: Sphere-forming cell
subpopulations with cancer stem cell properties in human hepatoma
cell lines. BMC Gastroenterol. 11:712011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
19
|
Pan Z, Hooley J, Smith DH, Young P,
Roberts PE and Mather JP: Establishment of human ovarian serous
carcinomas cell lines in serum free media. Methods. 56:432–439.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roberts PE: Isolation and establishment of
human tumor stem cells. Methods Cell Biol. 86:325–342. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ishii K, Usui S, Sugimura Y, Yoshida S,
Hioki T, Tatematsu M, Yamamoto H and Hirano K: Aminopeptidase N
regulated by zinc in human prostate participates in tumor cell
invasion. Int J Cancer. 92:49–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hashida H, Takabayashi A, Kanai M, Adachi
M, Kondo K, Kohno N, Yamaoka Y and Miyake M: Aminopeptidase N is
involved in cell motility and angiogenesis: Its clinical
significance in human colon cancer. Gastroenterology. 122:376–386.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tokuhara T, Hattori N, Ishida H, Hirai T,
Higashiyama M, Kodama K and Miyake M: Clinical significance of
aminopeptidase N in non-small cell lung cancer. Clin Cancer Res.
12:3971–3978. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun ZP, Zhang J, Shi LH, Zhang XR, Duan Y,
Xu WF, Dai G and Wang XJ: Aminopeptidase N inhibitor 4cc synergizes
antitumor effects of 5-fluorouracil on human liver cancer cells
through ROS-dependent CD13 inhibition. Biomed Pharmacother.
76:65–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kobayashi T, Miyawaki S, Tanimoto M,
Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K,
Ohmoto E, et al The Japan Leukemia Study Group: Randomized trials
between behenoyl cytarabine and cytarabine in combination induction
and consolidation therapy, and with or without ubenimex after
maintenance/intensification therapy in adult acute myeloid
leukemia. J Clin Oncol. 14:204–213. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang Y: School of Pharmacy, Shandong
University, PhD Dissertations, Development of novel anti-cancer
drugs base on aminopeptidase N/CD13. 2016
|
|
27
|
Huang YJ and Hsu SH: Acquisition of
epithelial-mesenchymal transition and cancer stem-like phenotypes
within chitosan-hyaluronan membrane-derived 3D tumor spheroids.
Biomaterials. 35:10070–10079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N,
Zhu Z, Mo Z, Wu C and Chen X: MiR-21 regulates
epithelial-mesenchymal transition phenotype and hypoxia-inducible
factor-1α expression in thirdsphere forming breast cancer stem
cell-like cells. Cancer Sci. 103:1058–1064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rybak AP, He L, Kapoor A, Cutz JC and Tang
D: Characterization of sphere-propagating cells with stem-like
properties from DU145 prostate cancer cells. Biochim Biophys Acta.
1813:683–694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu X, Wang Z, Li Y, Miao Y, Ren Y and
Luan Y: Characterization of sphere-forming cells with stem-like
properties from the small cell lung cancer cell line H446. Cancer
Lett. 323:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Di Lorenzo G, Rea A, Carlomagno C, Pepe S,
Palmieri G, Labianca R, Chirianni A, De Stefano A, Esposito V, De
Placido S, et al: Activity and safety of pegylated liposomal
doxorubicin, 5-fluorouracil and folinic acid in inoperable
hepatocellular carcinoma: A phase II study. World J Gastroenterol.
13:6553–6557. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amstutz U, Froehlich TK and Largiadèr CR:
Dihydropyrimidine dehydrogenase gene as a major predictor of severe
5-fluorouracil toxicity. Pharmacogenomics. 12:1321–1336. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamashita M, Wada H, Eguchi H, Ogawa H,
Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, Umeshita K, et al:
A CD13 inhibitor, ubenimex, synergistically enhances the effects of
anticancer drugs in hepatocellular carcinoma. Int J Oncol.
49:89–98. 2016.PubMed/NCBI
|
|
34
|
Naka K, Muraguchi T, Hoshii T and Hirao A:
Regulation of reactive oxygen species and genomic stability in
hematopoietic stem cells. Antioxid Redox Signal. 10:1883–1894.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chetram MA, Bethea DA, Odero-Marah VA,
Don-Salu-Hewage AS, Jones KJ and Hinton CV: ROS-mediated activation
of AKT induces apoptosis via pVHL in prostate cancer cells. Mol
Cell Biochem. 376:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilbertson RJ and Rich JN: Making a
tumour's bed: Glioblastoma stem cells and the vascular niche. Nat
Rev Cancer. 7:733–736. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Folkins C, Man S, Xu P, Shaked Y, Hicklin
DJ and Kerbel RS: Anticancer therapies combining antiangiogenic and
tumor cell cytotoxic effects reduce the tumor stem-like cell
fraction in glioma xenograft tumors. Cancer Res. 67:3560–3564.
2007. View Article : Google Scholar : PubMed/NCBI
|
